Roorkee Research & Analytical Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-12-2024
- Paid Up Capital ₹ 1.50 M
as on 13-12-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 14.67%
(FY 2022)
- Profit 32.91%
(FY 2022)
- Ebitda 11.41%
(FY 2022)
- Net Worth 11.41%
(FY 2022)
- Total Assets 2.85%
(FY 2022)
About Roorkee Research & Analytical Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nageswararao Manepalli, Sureshbabu Makam, and Naga Kanagarla serve as directors at the Company.
- CIN/LLPIN
U73100TG2006PTC051759
- Company No.
051759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Roorkee Research & Analytical Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nageswararao Manepalli  | Director | 30-Nov-2006 | Current |
| Sureshbabu Makam | Whole-Time Director | 22-Nov-2006 | Current |
| Naga Kanagarla | Director | 11-Dec-2020 | Current |
Financial Performance of Roorkee Research & Analytical Labs.
Roorkee Research & Analytical Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.67% increase. The company also saw a substantial improvement in profitability, with a 32.91% increase in profit. The company's net worth Soared by an impressive increase of 11.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roorkee Research & Analytical Labs?
In 2021, Roorkee Research & Analytical Labs had a promoter holding of 13.67% and a public holding of 86.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mmc Health Care LimitedActive 28 years 9 monthsNageswararao Manepalli and Sureshbabu Makam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Roorkee Research & Analytical Labs?
Unlock and access historical data on people associated with Roorkee Research & Analytical Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roorkee Research & Analytical Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roorkee Research & Analytical Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
